You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A{beta} Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial—Correction

Arch Neurol. 2004;61:776.

Error in Author Contributions. In the Original Contribution by Ritchie et al titled "Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A{beta} Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial," published in the December 2003 issue of the ARCHIVES (2003;60:1685-1691), an error occurred in the paragraph listing author contributions on page 1691. The contributions of Drs Bush and Tanzi were limited solely to study design and concept, and to consultation on biochemistry. The journal regrets the error.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.